fenofibric acid has been researched along with Atherogenesis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dullens, SP; Konings, M; Mensink, RP; Plat, J; Popeijus, HE; van der Krieken, SE | 1 |
| Chew, GT; Sahebkar, A; Watts, GF | 1 |
1 review(s) available for fenofibric acid and Atherogenesis
| Article | Year |
|---|---|
New peroxisome proliferator-activated receptor agonists: potential treatments for atherogenic dyslipidemia and non-alcoholic fatty liver disease.
Topics: Acetates; Animals; Atherosclerosis; Chalcones; Cholesterol, HDL; Dyslipidemias; Fatty Liver; Fenofibrate; Humans; Insulin Resistance; Lipoproteins, HDL; Non-alcoholic Fatty Liver Disease; Peroxisome Proliferator-Activated Receptors; Propionates; Quinolines; Sulfonamides; Thiazoles; Triazoles; Triglycerides | 2014 |
1 other study(ies) available for fenofibric acid and Atherogenesis
| Article | Year |
|---|---|
C/EBP-β Is Differentially Affected by PPARα Agonists Fenofibric Acid and GW7647, But Does Not Change Apolipoprotein A-I Production During ER-Stress and Inflammation.
Topics: Apolipoprotein A-I; Atherosclerosis; Butyrates; Caco-2 Cells; CCAAT-Enhancer-Binding Protein-beta; Endoplasmic Reticulum Stress; Fenofibrate; Gene Expression Profiling; Gene Silencing; Hep G2 Cells; Humans; Inflammation; Phenylurea Compounds; PPAR alpha; RNA, Messenger; Thapsigargin | 2017 |